Management

Scientific Advisory Board

Peter J. Barnes, FMedSci, F.R.S., Imperial College School of Medicine,

London, UK    Pulmonary diseases  

 

David Benditt, M.D., University of Minnesota Medical School, Minneapolis, MN

Cardiac electrophysiology, neurally-mediated syncope

 

Francesco DiVirgilio, M.D., University of Ferrara, Ferrara, Italy       

P2 receptors in immunology

 

Daniel Flammang, M.D., Centre Hospitalier d'Angouleme,  Angouleme, France 

ATP in the management of patients with syncope 

  

Jane Kinsel, Ph.D., M.B.A., Boston University, Boston, MA                  

Pharma industry, drug development

 

Donald A. McAfee, Ph.D., VP New Product Development,  Cardiome Pharma Corp., Vancouver, B.C., Canada    Biopharmacuetical industry, neurophysiology

 

Pasquale Patrizio, M.D., Yale University-Fertility Center, New Haven, CT

Andrology, male fertility

 

Riccardo Polosa, M.D., Ph.D., University of Catania, Catania, Italy.

Chronic obstructive pulmonary disorders

 

Jonathan S. Stamler, M.D., Duke University, Durham, NC

Nitric oxide signal transduction

 

 

Copyright © 2008 Duska Therapeutics, Inc. 1999-2008 All rights reserved.

 

Duska Therapeutics

info@duskatherapeutics.com

At the heart of cardiovascular medicine